# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-114889
Filing Date
2025-05-07
Accepted
2025-05-07 16:06:08
Documents
94
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d907688d10q.htm iXBRL | 10-Q | 1895049
2 | EX-31.1 | d907688dex311.htm | EX-31.1 | 10358
3 | EX-31.2 | d907688dex312.htm | EX-31.2 | 10343
4 | EX-32 | d907688dex32.htm | EX-32 | 4331
| Complete submission text file | 0001193125-25-114889.txt |  | 10851461

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20250331.xsd | EX-101.SCH | 93682
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20250331_cal.xml | EX-101.CAL | 48379
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20250331_def.xml | EX-101.DEF | 572053
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20250331_lab.xml | EX-101.LAB | 625379
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20250331_pre.xml | EX-101.PRE | 608663
97 | EXTRACTED XBRL INSTANCE DOCUMENT | d907688d10q_htm.xml | XML | 1996005

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 25921298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)